Novo Integrated Sciences Return on Tangible Equity 2012-2024 | NVOS
Current and historical return on tangible equity values for Novo Integrated Sciences (NVOS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Novo Integrated Sciences Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-08-31 | $-0.02B | $-0.01B | 357.89% |
| 2024-05-31 | $-0.03B | $0.00B | 769.23% |
| 2024-02-29 | $-0.01B | $0.00B | -2400.00% |
| 2023-11-30 | $-0.01B | $0.00B | -1120.00% |
| 2023-08-31 | $-0.01B | 0 | 0.00% |
| 2023-05-31 | $-0.03B | $0.00B | 2133.33% |
| 2023-02-28 | $-0.04B | $0.00B | 2000.00% |
| 2022-11-30 | $-0.04B | $0.00B | 2000.00% |
| 2022-08-31 | $-0.03B | -0 | 13200.00% |
| 2022-05-31 | $-0.01B | $0.00B | -866.67% |
| 2022-02-28 | $-0.01B | $0.00B | -257.14% |
| 2021-11-30 | $-0.01B | $0.00B | -142.86% |
| 2021-08-31 | $0.00B | $0.00B | -106.67% |
| 2021-05-31 | $-0.01B | $0.00B | -160.00% |
| 2021-02-28 | $-0.01B | $0.00B | -300.00% |
| 2020-11-30 | $-0.01B | $0.00B | -300.00% |
| 2020-08-31 | $-0.01B | $0.00B | -222.22% |
| 2020-05-31 | $0.00B | $0.00B | -40.00% |
| 2020-02-29 | $0.00B | $0.00B | -40.00% |
| 2019-11-30 | $0.00B | $0.00B | 0.00% |
| 2019-08-31 | $0.00B | $0.00B | 0.00% |
| 2019-05-31 | $0.00B | $0.00B | 0.00% |
| 2019-02-28 | $0.00B | $0.00B | 0.00% |
| 2018-11-30 | $0.00B | 0 | 0.00% |
| 2018-08-31 | $0.00B | $0.00B | 80.00% |
| 2018-05-31 | $0.00B | $0.00B | 80.00% |
| 2018-02-28 | $0.00B | $0.00B | 53.33% |
| 2017-11-30 | $0.00B | $0.00B | 26.67% |
| 2017-08-31 | $0.00B | $0.00B | 40.00% |
| 2017-03-31 | $0.00B | 0 | 0.00% |
| 2017-02-28 | $0.00B | 0 | 0.00% |
| 2016-11-30 | $0.00B | 0 | 0.00% |
| 2016-09-30 | $0.00B | 0 | 0.00% |
| 2016-05-31 | $0.00B | 0 | 0.00% |
| 2016-03-31 | $0.00B | 0 | 0.00% |
| 2015-06-30 | $0.00B | -0 | 800.00% |
| 2015-03-31 | $0.00B | $0.00B | 400.00% |
| 2014-06-30 | $0.00B | $0.00B | 0.00% |
| 2014-03-31 | $0.00B | $0.00B | 0.00% |
| 2013-09-30 | $0.00B | $0.00B | 0.00% |
| 2013-06-30 | $0.00B | $0.00B | 0.00% |
| 2012-12-31 | $0.00B | $0.00B | 0.00% |
| 2012-09-30 | $0.00B | $0.00B | 0.00% |
| 2012-03-31 | $0.00B | $0.00B | 100.00% |
| 2012-02-29 | $0.00B | $0.00B | 400.00% |
| 2011-11-30 | $0.00B | 0 | 0.00% |
| 2011-09-30 | $0.00B | 0 | 0.00% |
| 2011-08-31 | $0.00B | 0 | 0.00% |
| 2011-06-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |